Pertussis re-emergence in the post-vaccination era
Open Access
- 26 March 2013
- journal article
- review article
- Published by Springer Science and Business Media LLC in BMC Infectious Diseases
- Vol. 13 (1), 151
- https://doi.org/10.1186/1471-2334-13-151
Abstract
Background Resurgence of pertussis in the post-vaccination era has been reported in Western countries. A shift of cases from school-age children to adolescents, adults and children under 1 year of age has been described in the last decade, and mortality rates in infants are still sustained. We aimed to review and discuss the possible vaccination strategies which can be adopted in order to improve the pertussis control, by searches of Pubmed, and websites of US and European Centers for Disease Control and Prevention, between 1st January 2002, and 1st March 2013. Discussion The following vaccination strategies have been retrieved and analysed: the cocooning strategy, the immunization of pregnant women and newborns, vaccination programs for preschool children, adolescents, adults and health-care workers. Cost-effectiveness studies provide some contrasting data, mainly supporting both maternal vaccination and cocooning. Adolescent and/or adult vaccination seems to be cost-effective, however data from observational studies suggest that this vaccination strategy, used alone, leads to a reduced pertussis burden globally, but does not affect the disease incidence in infants. Moreover, substantial logistical and economic difficulties have to be overcome to vaccinate the largest number of individuals. Summary The simultaneous use of more than one strategy, including cocooning strategy plus vaccination of adolescents and adults, seems to be the most reasonable preventive measure. The development of new highly immunogenic and efficacious pertussis vaccines continues to be a primary objective for the control of pertussis.Keywords
This publication has 84 references indexed in Scilit:
- Modelling pertussis transmission to evaluate the effectiveness of an adolescent booster in ArgentinaEpidemiology and Infection, 2012
- Clinical Definitions of Pertussis: Summary of a Global Pertussis Initiative Roundtable Meeting, February 2011Clinical Infectious Diseases, 2012
- A critical literature review of health economic evaluations in pertussis booster vaccinationExpert Review of Pharmacoeconomics & Outcomes Research, 2012
- Accelerating Control of Pertussis in England and WalesEmerging Infectious Diseases, 2012
- The impact of adolescent pertussis immunization, 2004–2009: lessons from AustraliaBulletin of the World Health Organization, 2011
- Adult Vaccination Strategies for the Control of Pertussis in the United States: An Economic Evaluation Including the Dynamic Population EffectsPLOS ONE, 2009
- Neonatal Vaccination with an Acellular Pertussis Vaccine Accelerates the Acquisition of Pertussis Antibodies in InfantsThe Journal of Pediatrics, 2008
- Estimating the role of casual contact from the community in transmission of Bordetella pertussis to young infantsEmerging Themes in Epidemiology, 2007
- Risk factor studies of age-at-onset in a sample ascertained for Parkinson disease affected sibling pairs: a cautionary taleEmerging Themes in Epidemiology, 2007
- Live Attenuated B. pertussis as a Single-Dose Nasal Vaccine against Whooping CoughPLoS Pathogens, 2006